The Policy Shift: What Just Happened? In early July 2025, sweeping new legislation—nicknamed the “Big Beautiful Bill”—was signed into law. While the bill includes provisions for infrastructure, AI, and traditional energy expansion, it quietly eliminated or scaled back several green energy incentives that many innovators relied on: Reduced or eliminated federal tax credits for renewable [...]

On November 15, 2024, the United States Patent and Trademark Office (“USPTO”) announced that effective January 18, 2025, certain trademark filing fees are set to increase. The Final Rule is intended to “enable the USPTO to accomplish its mission to drive U.S. innovation, inclusive capitalism, and global competitiveness by delivering high-quality and timely trademark examination [...]

Joshua Goldberg of Nath, Goldberg & Meyer enlightens us on the standard for satisfying the written description requirement for negative claim limitations. Although the inherency doctrine is available, it has been recently called into question. Now many wait to hear the if the Federal Circuit Court will decide to rehear the case en banc that [...]

Joshua Goldberg of Nath, Goldberg & Meyer enlightens us on why it takes so long to get a patent improved and on a little known secret that can cut the decision time from 2-4 years to 1 year. The cost to take advantage of this program by the USPTO is only a few thousands [...]

The Trademark Modernization Act (TMA), going into effect December 18, 2021, will provide a faster and less expensive method to cancel trademark registrations based on non-use and abandonment. In addition, as of December 1, 2022, the deadline to respond to Office Actions for all non-Madrid based trademark applications will be three months, with a single [...]

HealthTech Networking Club, RapidConf event, March 25, 2021 at 8:30 – 10:30 PST / 16:30 – 18:30 GMT HealthTech business advisors present innovative growth strategies for Pharma and Medical Health companies. Panelists include investor Balint Bene, patent attorney Joshua Goldberg and other respected advisors to HealthTech businesses.

Kindly click to hear the full conversation between Joshua Goldberg and Yitz Rubin: